Pfizer Inc


Pfizer shares experienced a healthy 7.71% gain today as the company announced a patent victory on its biggest selling drug. This stock is technically interesting because it gapped up toward the combined resistance of the October highs and the 200 DMA. These levels have prevented the bulls from pushing the price higher on several previous occasions, and we believe that this may be the case again.


You May Also Like

Related Analysis
  1. Chart Advisor

    These 4 Stocks are Hitting Technical Headwinds

  2. Stock Analysis

    Will CMS Energy (CMS) Earnings Surprise Estimates in Q4? - Analyst Blog

  3. Stock Analysis

    Will Franklin (BEN) Q1 Earnings Disappoint Expectations? - Analyst Blog

  4. Stock Analysis

    Will Bemis (BMS) Disappoint on Q4 Earnings Estimates? - Analyst Blog

  5. Stock Analysis

    Will PACCAR (PCAR) Disappoint This Earnings Season? - Analyst Blog

Trading Center